Giovanni P.
- Country
- Italy
- Department
- Dipartimento Materno-Infantile – SC Pediratria ad indirizzo onco-ematologico
Research Overview
- Evaluation of Bortezomib, Blinatumomab, and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Randomized Controlled Trial
- Evaluation of Dexamethasone Versus Prednisone in Induction Therapy for Pediatric and Adolescent Lymphoblastic Lymphoma: A Randomized Controlled Trial
- Phase 3 Study of Busulfan, Melphalan, and Chemoimmunotherapy in High-Risk Neuroblastoma Patients with Insufficient Metastatic Response
Data & Insights
Has run more than one trial at 198 of 336 partner sites.
Specializations
Pediatric Sarcomas
Specialized focus on treating aggressive forms of rhabdomyosarcoma and Ewing sarcoma, with particular emphasis on developing innovative therapeutic approaches for high-risk and very high-risk cases.
- Multi-modal treatment strategies
- Advanced consolidation therapies
- Risk-adapted therapeutic protocols
Hematologic Malignancies
Expertise in treating acute lymphoblastic leukemia and lymphoblastic lymphoma in pediatric and adolescent populations, implementing targeted therapeutic approaches and immunotherapy protocols.
- Risk-stratified treatment protocols
- Immunotherapy applications
- CNS-directed therapies
Complex Pediatric Conditions
Focused work on high-risk neuroblastoma and sickle cell disease, developing comprehensive treatment strategies including chemotherapy, immunotherapy, and targeted molecular approaches.
- Novel drug combinations
- High-dose chemotherapy protocols
- Radiotherapy optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.